Nektium's botanical ingredient Zynamite granted US patent for brain-enhancing activities

14 Apr 2020

Zynamite is an all-natural evidence-based nootropic and sports performance ingredient, supported by clinical studies.

The United States Patent and Trademark Office has granted Nektium, a research-based branded botanical ingredient manufacturer based in Spain, a patent for its Compositions for Enhancing Brain Activity.

Nektium's botanical ingredient Zynamite granted US patent for brain-enhancing activities
Nektium's botanical ingredient Zynamite granted US patent for brain enhancing activities. (PRNewsfoto/Nektium)

This patent is part of the intellectual property portfolio supporting Nektium's innovative ingredient Zynamite, a caffeine-free botanical ingredient for mental and physical energy. Zynamite is a sustainable, proprietary standardized extract of leaves of a selection of Mangifera indica, the mango tree.

The caffeine-free and doping-free nootropic activities of Zynamite have been appearing in diverse finished product innovations including popular smart supplements and egaming formulations in Japan.

Recognising the fundamental importance of the mind in sports performance, Nektium applied the brain-activating activities of Zynamite to sports formulations, which have been subjected to four double-blind, randomised controlled clinical trials. The positive results of these sports performance and recovery studies have been published in four peer-reviewed papers.

"The currency of the nutraceutical ingredient industry is scientific evidence obtained from double-blind, randomised controlled clinical studies conducted by reputable academic departments and CROs, and published in leading peer-reviewed journals. Nektium has made a major investment in the clinical research backing Zynamite and continues to invest in ongoing clinical studies," said Dr Nigel Gericke, Nektium's Director of Science. "Our intention is to keep building the clinical research base and intellectual property supporting Zynamite as a premium branded ingredient."

Zynamite was first launched at Vitafoods in Geneva and HI Japan in Tokyo in 2018 and at Supply Side West in the USA in 2019.

The nutraceutical industry has already recognized the clinical research and innovation behind Zynamite awarding the ingredient five awards in the last 2 years: the Nutraingredients Award for sports ingredient of the year in 2018, the Nutraingredients Award for research in 2019, the Frost & Sullivan Award for innovation in 2019, and the European Specialised Sports Nutrition Awards for the 2019 best 'free from' ingredient, and the 2019 runner up award for game-changer ingredient of the year.

Read More

Related news

Can the industry really claim it's 'business as usual'?

Can the industry really claim it's 'business as usual'?

19 May 2020

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Read more 
HKBU scientists develop technique to eliminate drug side effects

HKBU scientists develop technique to eliminate drug side effects

19 May 2020

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

Read more 
Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

19 May 2020

The certification is expected to instill greater 'supply' trust with clients, particularly during the current pandemic.

Read more 
Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

18 May 2020

CDMO is contracted to produce multiple clinical batches from German facility

Read more 
Pharmapack expert recommends holistic approach to sustainability

Pharmapack expert recommends holistic approach to sustainability

18 May 2020

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Read more 
KND Labs earns Active Pharmaceutical Ingredients certification for CBD ingredients

KND Labs earns Active Pharmaceutical Ingredients certification for CBD ingredients

12 May 2020

Company's manufacturing methods and processes reviewed by an independent third-party auditor to ensure the products have the highest-quality ingredients possible.

Read more 
Characterizing virus and virus-like particles

Characterizing virus and virus-like particles

12 May 2020

New application study describes the separation and characterisation of adeno associated virus serotypes by AF4.

Read more 
Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand

Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand

12 May 2020

CDMO says it has made "notable changes" to its supply chain processes to ensure continuing supply of medicines during COVID-19 pandemic

Read more 
AI technology company launches with Novartis and Sarepta deals

AI technology company launches with Novartis and Sarepta deals

11 May 2020

Collaborations focus on gene therapies for serious eye and muscle diseases using Dyno’s CapsidMap artificial intelligence platform to design AAV vectors.

Read more 
Demand for immunity products to be sustained long-term says SIRIO

Demand for immunity products to be sustained long-term says SIRIO

11 May 2020

Movement towards healthy lifestyles and preventative supplements the lasting behavioural change post COVID-19.

Read more